VRNA — Verona Pharma Cashflow Statement
0.000.00%
HealthcareSpeculativeSmall CapFalling Star
- $252.34m
- $124.50m
- $40.00m
- 63
- 16
- 41
- 34
Annual cashflow statement for Verona Pharma, fiscal year end - December 31st, millions except per share.
2017 December 31st | 2018 December 31st | R2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | ||
Standards: | — | — | USG | USG | USG |
Status: | fx Preliminary | fx Preliminary | Final | Final | Final |
Net Income/Starting Line | |||||
Depreciation | |||||
Non-Cash Items | |||||
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | |||||
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | |||||
Capital Expenditures | |||||
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | |||||
Financing Cash Flow Items | |||||
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | |||||
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash |